Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere Vascular Study

By Niinisalo Petri   Oksala Niku   Levula Mari   Pelto-Huikko Markku   Järvinen Otso   Salenius Juha-Pekka   Kytömäki Leena   Soini Juhani T.   Kähönen Mika   Laaksonen Reijo   Hurme Mikko   Lehtimäki Terho  

Annals of Medicine, Vol. 42, Iss. 1, 2010-02 ,pp. : 55-63

Informa Healthcare

Access to resources Recommend Favorite

Treatment with granulocyte–macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock

By Schefold Joerg C.   Zeden Jan-Philip   Pschowski Rene   Hammoud Ben   Fotopoulou Christina   Hasper Dietrich   Fusch Gerhard   Haehling Stephan Von   Volk Hans-Dieter   Meisel Christian   Schütt Christine   Reinke Petra  

Scandinavian Journal of Infectious Diseases, Vol. 42, Iss. 3, 2010-02 ,pp. : 164-171

Informa Healthcare

Access to resources Recommend Favorite

Treg Cell Function in Rheumatoid Arthritis Is Compromised by CTLA‐4 Promoter Methylation Resulting in a Failure to Activate the Indoleamine 2,3‐Dioxygenase Pathway

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 9, 2014-09 ,pp. : 2344-2354

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiviral and Immunoregulatory Effects of Indoleamine-2,3-Dioxygenase in Hepatitis C Virus Infection

By  

Journal of Innate Immunity, Vol. 7, Iss. 5, 2015-03 ,pp. : 530-544

Karger

Access to resources Recommend Favorite

Molecular pathways and targets in cancer-related inflammation

By Mantovani Alberto   Garlanda Cecilia   Allavena Paola  

Annals of Medicine, Vol. 42, Iss. 3, 2010-04 ,pp. : 161-170

Informa Healthcare

Access to resources Recommend Favorite